Posted in | News | Solar Energy | Green Products

National Renewable Energy Laboratory Awards $3 million Subcontract to Semprius for Commercialization of Solar Energy Technology

National Renewable Energy Laboratory (NREL) has selected Semprius for negotiating a $3 million subcontract for the commercialization of its proprietary solar energy technology. U.S. Department of Energy (DOE) is funding the subcontract. Semprius is one among four companies that has been selected for NREL’s PV Technology Incubator Program. The goal of the PV Technology Incubator Program is to speed up the commercialization of solar photovoltaic systems.

The award from NREL confirms Semprius’ novel solar energy technology has the potential to make the generation of solar energy economically feasible. The company, based on its micro-transfer printing technology is commercializing its innovative solar module arrays.

The solar module arrays from the company offer multiple benefits such as high capacity factor, high efficiency and low installed cost. These factors enable the generation of solar electricity at very low costs in dry and sunny climates. In addition, the module’s scalable design enables it be utilized for distributed energy generation for industrial and commercial projects as well as for large scale utility installations.

Joe Carr, Semprius President and CEO, said that company is proud to be selected for the award and will utilize the subcontract for the development and demonstration of the novel solar technology at pilot plant scale, which is vital before proceeding with full scale production.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.